Rhythm control and cardioversion
- PMID: 16963490
- PMCID: PMC1861343
- DOI: 10.1136/hrt.2006.099879
Rhythm control and cardioversion
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Is early cardioversion of atrial fibrillation, facilitated by transesophageal echocardiography, safe and effective?J Fam Pract. 2001 Nov;50(11):925. J Fam Pract. 2001. PMID: 11711003 No abstract available.
-
[How to do: Cardioversion].Dtsch Med Wochenschr. 2016 May;141(10):706-8. doi: 10.1055/s-0042-103304. Epub 2016 May 13. Dtsch Med Wochenschr. 2016. PMID: 27176064 German.
-
The efficacy and tolerability of commonly used agents to prevent recurrence of atrial fibrillation after successful cardioversion.Am J Cardiovasc Drugs. 2014 Aug;14(4):241-51. doi: 10.1007/s40256-014-0064-5. Am J Cardiovasc Drugs. 2014. PMID: 24604773 Review.
-
[The use of transesophageal echocardiography in cardioversion for atrial fibrillation].G Ital Cardiol. 1995 Dec;25(12):1681-2. G Ital Cardiol. 1995. PMID: 8707020 Italian. No abstract available.
-
[Cardioversion of atrial fibrillation].Ugeskr Laeger. 2013 Oct 21;175(43):2549-53. Ugeskr Laeger. 2013. PMID: 24629150 Review. Danish.
Cited by
-
Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.PLoS One. 2019 Jan 3;14(1):e0210170. doi: 10.1371/journal.pone.0210170. eCollection 2019. PLoS One. 2019. PMID: 30605492 Free PMC article.
-
Practical Implementation of Anticoagulation Strategy for Patients Undergoing Cardioversion of Atrial Fibrillation.Arrhythm Electrophysiol Rev. 2017 Jun;6(2):50-54. doi: 10.15420/aer.2017:3:2. Arrhythm Electrophysiol Rev. 2017. PMID: 28835835 Free PMC article.
-
Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study.Front Physiol. 2021 Aug 30;12:718622. doi: 10.3389/fphys.2021.718622. eCollection 2021. Front Physiol. 2021. PMID: 34526912 Free PMC article.
-
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.Europace. 2016 Feb;18(2):184-90. doi: 10.1093/europace/euv294. Epub 2015 Oct 20. Europace. 2016. PMID: 26487668 Free PMC article. Clinical Trial.
References
-
- Lip G Y H, Li‐Saw‐Hee F L. Paroxysmal atrial fibrillation. QJM 200194665–678. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical